
Ryan Schwarz Managing Director
Mr. Schwarz has almost 30 years of investment and financial experience in healthcare. At NaviMed, he sits on the Firm’s Investment Committee and is responsible for leading investments and overseeing portfolio companies with a particular focus on payor services and technology-enabled outsourced services.
For fourteen years from 1997 to 2011, Mr. Schwarz led the U.S. healthcare growth capital practice at The Carlyle Group. His team’s investing activities focused on healthcare services, healthcare IT, and medical products. He joined The Carlyle Group at the inception of its initial U.S. venture and growth capital fund in 1997 and led the healthcare investing practice through all three of the firm’s domestic growth capital funds, which targeted growth and venture capital investments and growth-oriented leveraged buyouts.
Mr. Schwarz previously was a Vice President in the healthcare group at Robertson Stephens, where he led the firm’s health IT investment banking efforts and also served clients in the healthcare services sector. Earlier in his career, Mr. Schwarz was an investment banker at Morgan Stanley.
Mr. Schwarz is currently the Chairman of the Boards of Directors of NeuLife Neurological and OPN Healthcare. He previously served as Chairman of the Boards of Directors of Argos Health and Lucent Health.
Mr. Schwarz holds an AB from Duke University where he was an Angier B. Duke Scholar, an MBA from Harvard Business School, and a JD from Harvard Law School.
Email Ryan Schwarz